Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M J Moro

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
Blood|January 15, 1995
A new staging system for multiple myeloma based on the number of S-phase plasma cellsJ F San Miguel, R García-Sanz, M González, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1993
Alternating combination VCMP/VBAP chemotherapy versus melphalan/prednisone in the treatment of multiple myeloma: a randomized multicentric study of 487 patientsJ Bladé, J F San Miguel, A Alcalá, et al.
Annals of Hematology|November 1, 1993
Lymphoid subsets in acute myeloid leukemias: increased number of cells with NK phenotype and normal T-cell distributionM B Vidriales, A Orfao, M C López-Berges, et al.
Age and Ageing|September 1, 1996
Treatment of multiple myeloma in elderly people: long-term results in 178 patientsJ Bladé, M Muñoz, M Fontanillas, et al.
Pathologie-Biologie|April 8, 1999
Immunophenotypic and DNA content characteristics of plasma cells in multiple myeloma and monoclonal gammopathy of undetermined significanceJ Almeida, A Orfao, G Mateo, et al.
Cytometry|May 14, 1999
An abnormal CD34+ myeloid/CD34+ lymphoid ratio at the end of chemotherapy predicts relapse in patients with acute myeloid leukemiaA Martínez, J F San Miguel, M B Vidriales, et al.
Blood|May 23, 1998
Prognostic value of numerical chromosome aberrations in multiple myeloma: A FISH analysis of 15 different chromosomesJ A Pérez-Simón, R García-Sanz, M D Tabernero, et al.
Leukemia|July 30, 2002
Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigationM L Sánchez, J Almeida, B Vidriales, et al.
British Journal of Haematology|April 1, 1996
Analysis of natural killer-associated antigens in peripheral blood and bone marrow of multiple myeloma patients and prognostic implicationsR García-Sanz, M González, A Orfão, et al.
Blood|January 28, 1999
Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristicsR García-Sanz, A Orfão, M González, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
Blood|January 15, 1995
A new staging system for multiple myeloma based on the number of S-phase plasma cellsJ F San Miguel, R García-Sanz, M González, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1993
Alternating combination VCMP/VBAP chemotherapy versus melphalan/prednisone in the treatment of multiple myeloma: a randomized multicentric study of 487 patientsJ Bladé, J F San Miguel, A Alcalá, et al.
Annals of Hematology|November 1, 1993
Lymphoid subsets in acute myeloid leukemias: increased number of cells with NK phenotype and normal T-cell distributionM B Vidriales, A Orfao, M C López-Berges, et al.
Age and Ageing|September 1, 1996
Treatment of multiple myeloma in elderly people: long-term results in 178 patientsJ Bladé, M Muñoz, M Fontanillas, et al.
Pathologie-Biologie|April 8, 1999
Immunophenotypic and DNA content characteristics of plasma cells in multiple myeloma and monoclonal gammopathy of undetermined significanceJ Almeida, A Orfao, G Mateo, et al.
Cytometry|May 14, 1999
An abnormal CD34+ myeloid/CD34+ lymphoid ratio at the end of chemotherapy predicts relapse in patients with acute myeloid leukemiaA Martínez, J F San Miguel, M B Vidriales, et al.
Blood|May 23, 1998
Prognostic value of numerical chromosome aberrations in multiple myeloma: A FISH analysis of 15 different chromosomesJ A Pérez-Simón, R García-Sanz, M D Tabernero, et al.
Leukemia|July 30, 2002
Incidence of phenotypic aberrations in a series of 467 patients with B chronic lymphoproliferative disorders: basis for the design of specific four-color stainings to be used for minimal residual disease investigationM L Sánchez, J Almeida, B Vidriales, et al.
British Journal of Haematology|April 1, 1996
Analysis of natural killer-associated antigens in peripheral blood and bone marrow of multiple myeloma patients and prognostic implicationsR García-Sanz, M González, A Orfão, et al.
Blood|January 28, 1999
Primary plasma cell leukemia: clinical, immunophenotypic, DNA ploidy, and cytogenetic characteristicsR García-Sanz, A Orfão, M González, et al.
Pageof 6